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 SUMMARY 
Previous literature has produced mixed results on the effects of country health expenditures on 
longevity.  More importantly, all previous studies have evaluated the expenditure effects on the 
mean of the life expectancy distribution, ignoring the possibility that the expenditure returns may 
not be the same for countries that differ in their life expectancies.  In this paper, we evaluate the 
heterogeneity in country health expenditure effects throughout the life expectancy distribution 
applying quantile regression to an assembled dataset of 177 countries.  We find significant 
heterogeneities in expenditures effects on life expectancy that are completely masked by 
ordinary least squares (OLS), which underestimates (overestimates) the expenditure returns for 
countries ranking at low (high) life-expectancy quantiles. The largest returns from increased 
spending are for countries at the left margin of the life expectancy distribution (mainly at 
quantiles 0.25 and lower), for which a $100 increase in per capita spending leads to 11.5 and 11 
months of life for males and females, respectively. The results suggest that increasing healthcare 







 1. INTRODUCTION 
Previous literature has produced mixed results on the effects of population-level health 
expenditures on average life expectancy across countries. For example, in a study of several 
OECD countries, Wolfe (1986) found that when life-style (smoking, drinking and accidents), 
inflation and population size are accounted for, health expenditures have a positive effect on life 
expectancy. On the other hand, McCarthy and Wolf (2001) found that health expenditures are 
not well predictive of life expectancy in Africa, compared to access to health services, clean 
water, sanitation and education. This mixed empirical evidence suggests that health expenditure 
effects on life expectancy may vary between countries, possibly due to differences in population 
and economic factors that modify the expenditure effects.  From this perspective using ordinary 
least squares (OLS) to estimate expenditure effects on life expectancy mean (i.e. for the 
“average” country) may be inadequate in the presence of possible unobserved heterogeneity 
between countries.   
Theory would also support this heterogeneity. For example, increasing average healthcare 
spending by $100 per capita is expected to result in much higher returns in life expectancy in 
poorer countries with low life expectancy where several low-cost improvements in health can 
still be achieved especially by treating and preventing infectious diseases. In contrast, the same 
increase in spending in richer countries with high life expectancy is unlikely to result in a similar 
gain in life expectancy since the well-established public health infrastructures and advanced 
medical technology have already resulted in significant health and longevity improvements 
(Cutler, 2006).  Such a heterogeneity does not only occur because of the diminishing marginal 
returns of spending, but due to interactions between spending and several country characteristics 
that may modify spending effects such as population demographic, economic, social, cultural, and environmental factors.  Therefore, simply accounting for diminishing marginal returns in 
OLS does not address this heterogeneity. 
In this paper, we employ quantile regression to evaluate the heterogeneity in country 
health expenditure effects at various locations of the life expectancy distribution, while allowing 
for diminishing marginal returns of expenditures at each location by including squared 
expenditure terms.  This is the first study to formally evaluate the heterogeneity in life 
expectancy returns from health expenditures for countries at different ranks of the life 
expectancy distribution. 
2. METHODS 
2.1. Estimation approach 
Our model is based on a country-level analysis of the country’s life expectancy (LE) as a 
function of its per capita spending on health (HE) controlling for conceptually relevant 
socioeconomic and demographic characteristics (X); the country is the unit of the analysis.  We 
estimate this model separately for males and females due to differences in their health 
characteristics and disease epidemiology which may modify expenditure effects.  We model the 
conditional quantiles of LE as follows: 
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In this equation q is the quantile rank between 0 and 1, and Q is the conditional qth quantile of 
LE. We estimate this function using quantile regression (QR) to identify the health expenditure 
effects (β) at different quantiles of the country-level life expectancy distribution. When estimating these effects on a certain quantile q, QR holds constant at that specific quantile the net 
value of the unobserved country-level factors that determine the countries’ rank on the life 
expectancy  distribution and that result in countries with similar observable characteristics (HE 
and X) to have different life expectancies.  This is why QR estimates may be interpreted as 
representing expenditure effects by the heterogeneity in unobserved relevant factors for life 
expectancy (Chernozhukov and Hansen, 2005; Wehby et al., 2009).  We estimate QR by 
minimizing the weighted sum of absolute deviations for each observation i (country) between the 
conditioned and actual LE for q ranging from 0.05 to 0.95 in increments of 0.05 (Koenker and 
Bassett, 1978; Koenker and Hallock, 2001): 
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We estimate the variance-covariance matrix using bootstrap with 1,000 replications and test 
differences in expenditure effects between different quantiles using standard Wald tests (Hao and 
Naiman, 2007).  For comparison to the QR results, we also estimate the expenditure effects on 
mean life expectancy using OLS. 
 
2.2 Data 
Data are taken from the World Development Indicators (WDI) database (World Bank) for 
years 2006-2008 for life expectancy, for years 1997-1999 for health expenditures, and for 2005-
2007 for model covariates.  We lag health expenditures 10 years in order to mitigate the 
simultaneity problem between health expenditures and life expectancy – countries with better life 
expectancy may have better productivity and spend more on health – and to allow for reasonable time for spending effects to occur.  To further reduce simultaneity issues, we also lag other 
pecuniary covariates by one year. We decided not to impute any missing values for three key 
variables of interest: female and male life expectancy at birth and health expenditure per capita 
in current USD. This leaves us with an unbalanced panel of 531 observations with up to three 
waves of data for most of the 177 countries.  
We control for lagged Gross National Income (GNI) per capita and Net Official 
Development Assistance (ODA) received per capita (both in current USD); Net ODA is set to 0 
for non-receiving countries.  We include female labor force participation rate (% of female 
population ages 15+) and public health expenditure as percent of GDP, which capture additional 
aspects of economic development.  We also control for access rates to clean water and sanitation 
which are considered key factors for life expectancy (McCarthy and Wolf, 2001). Since there are 
no data on these two variables for 2006 and 2007, we use 2005 data for all three waves. We also 
include percent of urban population in order to account for different levels of access to modern 
health technology. 
Ideally, we would also include additional covariates such as measures of inequality (Gini 
coefficient), road and public transport infrastructure, and education rates in order to further 
reduce the problem of endogeneity between healthcare spending and life expectancy. However, 
the WDI database has only a handful of non-missing observations for these additional variables 
which prevented us from including them. We do not include a measure of fertility because it is 
clearly endogenous to life expectancy and may be on the causal pathway between health 
expenditure and life expectancy. In the final set of included control variables, GNI per capita is 
missing in 19 cases (country-year observations), access to clean water and improved sanitation 
are missing in 34 and 40 cases, respectively, and female labor force participation is missing in 16 cases. Since excluding these observations would substantially reduce our sample size, we set 
missing values to the observation in previous or, if not available, in next year for each country. If 
a country has missing values in all three years for a particular covariate we set it to the median 
for the continent. Table 1 provides descriptive statistics on the model variables. 
 
3. RESULTS 
In 1997-1999 countries spent anywhere between 1.87 and 4291.07 USD per capita on 
health expenditures with a mean of 417.15 dollars, and had Female LE (FLE) from 42.9 to 86.1 
and Male LE (MLE) from 41.4 and 80.0 years.  
Table 2 shows the expenditure effects at 0.1, 0.25, 0.5, 0.75 and 0.9 quantiles for female 
and male life expectancy, which provide good coverage for the entire LE distribution. Figures 1 
and 2 show the expenditures effects for the 19 quantiles (0.05 through 0.95).  For both males and 
females, health expenditures have the expected positive effect on LE, but overall have larger 
effects at lower than higher quantiles. A 100$ increase in health expenditures from the mean of 
417 $ is associated with 11 and 11.5 additional months gained for females and males, 
respectively, at the 0.1 quantile, compared to only 4.1 and 3.5 months, respectively, at the 0.9 
quantile. Squared health expenditures have the expected negative sign due to diminishing 
marginal effect of expenditures at all quantiles. The expenditures and expenditures squared 
effects are significant at all quantiles at p<0.01 except for the last.  The differences in 
expenditure effects between the five quantiles in Table 2 are significant for both females (p= 
0.037) and males (p = 0.003).  The OLS effects clearly mask the heterogeneity in expenditure effects. Based on OLS, an increase of $100 in health expenditures per capita is associated with 
6.5 and 7.2 more months of mean life expectancy in women and men, respectively (Table 2). 
Other variables of interest have the expected effects on LE. Access to clean water has the 
largest effect on LE at lower quantiles among all covariates, but the effect diminishes at higher 
quantiles. Similarly, gross national product and the amount of development assistance have 
higher and more significant effects at lower quantiles.
1 
4. DISCUSSION AND CONCLUSIONS 
We show in this paper that health expenditures may have different effects on life 
expectancy for countries with different ranks on the life expectancy distribution. Specifically, 
increased expenditures have larger effects at the left margin of the LE distribution, i.e. for 
countries with lower life expectancies.  There are many unobserved factors that determine the 
country’s rank on the LE distribution and that may lead to different health expenditure effects on 
LE such as the types and magnitude of disease risks, population economic and demographic 
characteristics, geographic effects, and the supply and quality of healthcare services.  The results 
suggest that countries with the largest need for increasing healthcare spending as measured by 
their poor LE performance will benefit the most in terms of increased LE from additional 
spending.  As theorized above, this may occur due to the high prevalence of acute health 
problems that may have large detrimental effects on LE but that can be effectively reduced by 
healthcare interventions such as childhood infectious diseases which can be significantly lowered 
by vaccinations and proper treatments.   
                                                            
1 Complete results of all regressions are available upon request. Ignoring this unobserved heterogeneity between countries may lead to underestimation of 
the effects of health expenditures per capita on LE for countries with low LE and overestimation 
of these effects for those with higher LE. Estimating these effects on the mean LE (i.e. for the 
average country) underestimates the effects for countries at low LE quantiles by up to 69.7% and 
59.4% and overestimates the effect for countries at high LE quantiles by up to 37.3% and 51.9% 
for females and males.  These results suggest that other multi-country studies of income, 
spending or other healthcare effects should recognize the significant unobserved heterogeneity 
between countries and should not employ estimation approaches that mask such heterogeneity 
such as OLS. 
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Table 1. Descriptive statistics         
Variable Mean 
Std. 
Dev. Min Max 
Female  life  expectancy  70.66 10.92 42.93 86.05 
Male  life  expectancy  65.92 9.72 41.42 79.98 
Health expenditure per capita (lagged 10 yrs)  4.17  7.86  0.02  42.91 
Health expenditure squared (lagged 10 yrs)  79.10  240.83  0.00  1841.33
GNI per capita (lagged 1 year)  93.45  146.06  1.00  787.70 
Net Official Development Assistance (lagged 1 year)  0.54  1.11  -0.40  10.43 
% of population with access to sanitation  70.11  30.09  9.00  101.00 
% of population with access to clean water  84.94  16.78  35.00  100.00 
% of public health expenditures in total  3.74  2.20  0.19  14.13 
Female labor force participation, %  52.98  14.89  13.30  91.00 
Female population, %  50.07  2.85  24.75  53.98 
Urban population, %  54.74  22.79  9.80  100.00 
*Note: All monetary variables are in 100 of USD       
 
Table 2. The effects of health expenditures at different quantiles vs OLS estimates 
         Female LE          Male LE    
    Coef.  Std. Err.  p-value    Coef.  Std. Err.  p-value 
OLS HE    0.674  0.215 0.002    0.745  0.207  0.000 
 HE
2 -0.014  0.005  0.003   -0.015  0.005  0.001 
Quantile                
10
th HE    1.147  0.207  0.000    1.188  0.237  0.000 
 HE
2 -0.024  0.005  0.000   -0.025  0.007  0.001 
               
25
th HE    0.704  0.118  0.000    1.135  0.171  0.000 
 HE
2 -0.014  0.003  0.000   -0.025  0.005  0.000 
               
50
th HE    0.528  0.092  0.000    0.731  0.148  0.000 
 HE
2 -0.012  0.002  0.000   -0.016  0.003  0.000 
               
75
th HE    0.587  0.170  0.001    0.534  0.118  0.000 
 HE
2 -0.012  0.004  0.002   -0.012  0.003  0.000 
               90
th HE    0.413  0.190  0.030    0.351  0.215  0.104 
   HE
2 -0.007  0.003  0.026   -0.006  0.004  0.095 
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Figure 1. Female life expectancy.  
Notes:Y-axis denotes expenditure effects at LE quantiles at x-axis. Dashed line represents QR 
effects with the shaded area representing 95% interval. The solid horizontal line depicts the OLS 
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Figure 2. Male life expectancy. 
Notes:Y-axis denotes expenditure effects at LE quantiles at x-axis. Dashed line represents QR 
effects with the shaded area representing 95% interval. The solid horizontal line depicts the OLS 
effect.  
 